Võrdle meetodeid

	Kilpnäärme ületalitluse sümptomite kontroll-loend	TED-QoL / GO-QoL: Kilpnäärme silmahaiguse elukvaliteedi küsimustik
Valdkond	Endokrinoloogia	Endokrinoloogia
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	1997	2001
Looja	Multiple authors; consensus from Endocrine Society	Caroline Terwee, Markus Gerding, Frank Dekker
Tüüp	Patient self-report symptom checklist	Patient self-report questionnaire
Algallikas	Engel, G. L., Dayan, A. D., Thorn, G. W., et al. (1997). Hyperthyroidism: A multisystem disease with diverse manifestations. Adv Intern Med, 42, 55-91.	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.
Rööpnimetused	HSC, Hyperthyroid Symptom Inventory	GO-QoL, Graves Ophthalmopathy Quality of Life
Seotud	3	3
Kokkuvõte	The Hyperthyroidism Symptom Checklist is a structured assessment tool for quantifying the symptom burden of Graves' disease and other thyrotoxicosis conditions. It captures the multisystem manifestations of excess thyroid hormone: cardiovascular (palpitations, tachycardia, arrhythmia), neuropsychiatric (anxiety, tremor, insomnia), metabolic (heat intolerance, weight loss, appetite), and eye-specific symptoms (in Graves' ophthalmopathy). Used in endocrinology practice and clinical trials to monitor disease activity and treatment response.	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.